ABOUT AREXVY

What Is AREXVY?

AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory
syncytial virus (RSV) in:

  • people 60 years of age and older;
  • people 50 through 59 years of age at increased risk for LRTD caused by RSV.*

*Increased risk includes people with conditions like:

Lungs icon

Respiratory
disease

Liver icon

Liver
disease

Heartbeat icon

Cardiovascular
disease

Kidneys icon

Kidney
disease

Hand icon

Diabetes

Effective Against RSV

AREXVY was proven effective in a large study with people 60+ years.

OVER82%

EFFECTIVE

in preventing lung and lower airway infection from RSV in people aged 60 years and older

OVER94%

EFFECTIVE

in preventing lung and lower airway infection from RSV in people aged 60 years and older with asthma, diabetes, chronic obstructive pulmonary disease (COPD), chronic heart failure, advanced liver or kidney disease, or any chronic respiratory or pulmonary disease

Effectiveness in adults 50-59 at increased risk was based on the immune response compared to that seen in adults 60+.

For People 60+ and Those 50-59 Who Are at Increased Risk for RSV

60 years plus icon

AREXVY is available in
pharmacies

Check mark icon

AREXVY can be given at the same
time as a flu vaccine

Syringe icon

AREXVY is given as a single-dose shot

Find AREXVY near you GET AREXVY

How Does AREXVY Work?

AREXVY boosts your body’s protection against RSV, which can cause lower respiratory tract disease (LRTD). AREXVY is purposefully designed to stimulate the immune response to protect against RSV.

An Aging Immune System

As adults age, the immune system may weaken, and the body can have a more difficult time defending against infections like RSV.

Need a reminder to get AREXVY?

SIGN UP HERE

Get questions to ask your doctor about AREXVYFAQs

ABOUT AREXVY

What Is AREXVY?

AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in:

  • people 60 years of age and older;
  • people 50 through 59 years of age at increased risk for LRTD caused by RSV.*

*Increased risk includes people with conditions like:

Lungs icon

Respiratory
disease

Liver icon

Liver
disease

Heartbeat icon

Cardiovascular
disease

Kidneys icon

Kidney
disease

Hand icon

Diabetes

Effective Against RSV

AREXVY was proven effective in a large study with people 60+ years.

OVER82%

EFFECTIVE

in preventing lung and lower airway infection from RSV in people aged 60 years and older

OVER94%

EFFECTIVE

in preventing lung and lower airway infection from RSV in people aged 60 years and older with asthma, diabetes, chronic obstructive pulmonary disease (COPD), chronic heart failure, advanced liver or kidney disease, or any chronic respiratory or pulmonary disease

Effectiveness in adults 50-59 at increased risk was based on the immune response compared to that seen in adults 60+.

For People 60+ and Those 50-59 Who Are at Increased Risk for RSV

location-icon

AREXVY is available in
pharmacies

AREXVY can be given at the same
time as a flu vaccine

syringe-icon

AREXVY is given as a
single-dose shot

Find AREXVY near you

GET AREXVY

How Does AREXVY Work?

AREXVY boosts your body’s protection against RSV, which can cause lower respiratory tract disease (LRTD). AREXVY is purposefully designed to stimulate the immune response to protect against RSV.

An Aging Immune System

As adults age, the immune system may weaken, and the body can have a more difficult time defending against infections like RSV.

Need a reminder to get
AREXVY?

SIGN UP HERE

Get questions to ask your doctor
about AREXVY


FAQs

Location pin icon

GET AREXVY

See when and where you can get AREXVY.


FIND AREXVY

Hand icon

GET VACCINE REMINDERS

Sign up for reminders about getting AREXVY.


REMIND ME

Information icon

STAY INFORMED

Sign up for more information about RSV and AREXVY.


SIGN UP

RSV? Make it

Ask your doctor.